Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Virpax Pharmaceuticals, Inc. (VRPX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Virpax Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1708331.
Total stock buying since 2021: $253,451.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 84,729 | $113,419 | 0 | $0 | 0 | $0 |
| 2021 | 32,625 | $140,032 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-05 | 84,729 | $113,419 | 0 | $0 | 0 | $0 |
| 2021-11 | 29,025 | $115,555 | 0 | $0 | 0 | $0 |
| 2021-02 | 3,600 | $24,477 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-24 | Sendrow Jerrold | Buy | 4,500 | 1.29 | 5,805 |
| 2022-05-18 | Mack Anthony P. (Chief Executive Officer) | Buy | 75,750 | 1.34 | 101,505 |
| 2022-05-18 | Floyd Eric | Buy | 4,479 | 1.36 | 6,109 |
| 2021-11-22 | Sendrow Jerrold | Buy | 3,900 | 3.92 | 15,307 |
| 2021-11-18 | Mack Anthony P. (Chief Executive Officer) | Buy | 25,125 | 3.99 | 100,248 |
| 2021-02-17 | Jambulingam Thani | Buy | 100 | 7.16 | 716 |
| 2021-02-17 | Jacob Gary S | Buy | 3,500 | 6.79 | 23,761 |
Insider trading activities including stock purchases, stock sales, and option exercises of VRPX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Virpax Pharmaceuticals, Inc. (symbol VRPX, CIK number 1708331) see the Securities and Exchange Commission (SEC) website.